BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li H, Ying T, Yu F, Lu L, Jiang S. Development of therapeutics for treatment of Ebola virus infection. Microbes Infect 2015;17:109-17. [PMID: 25498866 DOI: 10.1016/j.micinf.2014.11.012] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 4.1] [Reference Citation Analysis]
Number Citing Articles
1 Cao P, Bai H, Wang X, Che J. Role of the Ebola membrane in the protection conferred by the three-mAb cocktail MIL77. Sci Rep 2018;8:17628. [PMID: 30514891 DOI: 10.1038/s41598-018-35964-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
2 Zhao J, Fang S, Liu Y, Zeng L, He Z. A lateral flow biosensor based on gold nanoparticles detects four hemorrhagic fever viruses. Anal Methods 2020;12:5613-20. [PMID: 33184619 DOI: 10.1039/d0ay01137a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Wang SR, Zhang QY, Wang JQ, Ge XY, Song YY, Wang YF, Li XD, Fu BS, Xu GH, Shu B, Gong P, Zhang B, Tian T, Zhou X. Chemical Targeting of a G-Quadruplex RNA in the Ebola Virus L Gene. Cell Chem Biol 2016;23:1113-22. [PMID: 27617851 DOI: 10.1016/j.chembiol.2016.07.019] [Cited by in Crossref: 67] [Cited by in F6Publishing: 58] [Article Influence: 13.4] [Reference Citation Analysis]
4 Pacheco DA, Rodrigues AA, Silva CM. Ebola virus - from neglected threat to global emergency state. Rev Assoc Med Bras (1992) 2016;62:458-67. [PMID: 27656857 DOI: 10.1590/1806-9282.62.05.458] [Reference Citation Analysis]
5 Liu Y, Wen Z, Carrion R Jr, Nunneley J, Staples H, Ticer A, Patterson JL, Compans RW, Ye L, Yang C. Intradermal Immunization of EBOV VLPs in Guinea Pigs Induces Broader Antibody Responses Against GP Than Intramuscular Injection. Front Microbiol 2020;11:304. [PMID: 32174901 DOI: 10.3389/fmicb.2020.00304] [Reference Citation Analysis]
6 Liu Q, Fan C, Li Q, Zhou S, Huang W, Wang L, Sun C, Wang M, Wu X, Ma J, Li B, Xie L, Wang Y. Antibody-dependent-cellular-cytotoxicity-inducing antibodies significantly affect the post-exposure treatment of Ebola virus infection. Sci Rep 2017;7:45552. [PMID: 28358050 DOI: 10.1038/srep45552] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 9.0] [Reference Citation Analysis]
7 Ghosh S, Saha A, Samanta S, Saha RP. Genome structure and genetic diversity in the Ebola virus. Curr Opin Pharmacol 2021;60:83-90. [PMID: 34364102 DOI: 10.1016/j.coph.2021.06.010] [Reference Citation Analysis]
8 Kieh MD, Cho EM, Myles IA. Contrasting academic and lay press print coverage of the 2013-2016 Ebola Virus Disease outbreak. PLoS One 2017;12:e0179356. [PMID: 28640889 DOI: 10.1371/journal.pone.0179356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
9 Sharma AR, Lee YH, Nath S, Lee SS. Recent developments and strategies of Ebola virus vaccines. Curr Opin Pharmacol 2021;60:46-53. [PMID: 34329960 DOI: 10.1016/j.coph.2021.06.008] [Reference Citation Analysis]
10 Jin Y, Lei C, Hu D, Dimitrov DS, Ying T. Human monoclonal antibodies as candidate therapeutics against emerging viruses. Front Med 2017;11:462-70. [PMID: 29159596 DOI: 10.1007/s11684-017-0596-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
11 Li H, Yu F, Xia S, Yu Y, Wang Q, Lv M, Wang Y, Jiang S, Lu L. Chemically Modified Human Serum Albumin Potently Blocks Entry of Ebola Pseudoviruses and Viruslike Particles. Antimicrob Agents Chemother 2017;61:e02168-16. [PMID: 28167539 DOI: 10.1128/AAC.02168-16] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
12 Huang G. Artificial infectious disease optimization: A SEIQR epidemic dynamic model-based function optimization algorithm. Swarm Evol Comput 2016;27:31-67. [PMID: 32288989 DOI: 10.1016/j.swevo.2015.09.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
13 Singleton CD, Humby MS, Yi HA, Rizzo RC, Jacobs A. Identification of Ebola Virus Inhibitors Targeting GP2 Using Principles of Molecular Mimicry. J Virol 2019;93:e00676-19. [PMID: 31092576 DOI: 10.1128/JVI.00676-19] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
14 Hao D, Wang Y, Li L, Qian G, Liu J, Li M, Zhang Y, Zhou R, Yan D. SHP-1 suppresses the antiviral innate immune response by targeting TRAF3. FASEB J 2020;34:12392-405. [PMID: 32779804 DOI: 10.1096/fj.202000600RR] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 van der Linden WA, Schulze CJ, Herbert AS, Krause TB, Wirchnianski AA, Dye JM, Chandran K, Bogyo M. Cysteine Cathepsin Inhibitors as Anti-Ebola Agents. ACS Infect Dis 2016;2:173-9. [PMID: 27347558 DOI: 10.1021/acsinfecdis.5b00130] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
16 Kaushik A, Tiwari S, Dev Jayant R, Marty A, Nair M. Towards detection and diagnosis of Ebola virus disease at point-of-care. Biosens Bioelectron 2016;75:254-72. [PMID: 26319169 DOI: 10.1016/j.bios.2015.08.040] [Cited by in Crossref: 94] [Cited by in F6Publishing: 73] [Article Influence: 13.4] [Reference Citation Analysis]
17 Loughran HM, Han Z, Wrobel JE, Decker SE, Ruthel G, Freedman BD, Harty RN, Reitz AB. Quinoxaline-based inhibitors of Ebola and Marburg VP40 egress. Bioorg Med Chem Lett 2016;26:3429-35. [PMID: 27377328 DOI: 10.1016/j.bmcl.2016.06.053] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]
18 Wang X, Zou P, Wu F, Lu L, Jiang S. Development of small-molecule viral inhibitors targeting various stages of the life cycle of emerging and re-emerging viruses. Front Med 2017;11:449-61. [PMID: 29170916 DOI: 10.1007/s11684-017-0589-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
19 Bai JPF, Hsu CW. Drug Repurposing for Ebola Virus Disease: Principles of Consideration and the Animal Rule. J Pharm Sci 2019;108:798-806. [PMID: 30244014 DOI: 10.1016/j.xphs.2018.09.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
20 Martínez MJ, Salim AM, Hurtado JC, Kilgore PE. Ebola Virus Infection: Overview and Update on Prevention and Treatment. Infect Dis Ther 2015;4:365-90. [PMID: 26363787 DOI: 10.1007/s40121-015-0079-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
21 Janeba Z. Development of Small-Molecule Antivirals for Ebola. Med Res Rev 2015;35:1175-94. [PMID: 26172225 DOI: 10.1002/med.21355] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
22 Yusim K, Yoon H, Foley B, Feng S, Macke J, Dimitrijevic M, Abfalterer W, Szinger J, Fischer W, Kuiken C, Korber B. Integrated sequence and immunology filovirus database at Los Alamos. Database (Oxford) 2016;2016:baw047. [PMID: 27103629 DOI: 10.1093/database/baw047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Kiselev OI, Vasin AV, Shevyryova MP, Deeva EG, Sivak KV, Egorov VV, Tsvetkov VB, Egorov AY, Romanovskaya-Romanko EA, Stepanova LA, Komissarov AB, Tsybalova LM, Ignatjev GM. Ebola hemorrhagic fever: Properties of the pathogen and development of vaccines and chemotherapeutic agents. Mol Biol 2015;49:480-93. [PMID: 32214474 DOI: 10.1134/S002689331504007X] [Cited by in Crossref: 5] [Article Influence: 0.7] [Reference Citation Analysis]